US › Healthcare

Biofrontera Inc (BFRI)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.22+2.52%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$10.1M
Revenue YoY
+17.4%
Net profit
$-4.8M
Profit YoY
-13.1%
EPS
$-0.41
EPS estimate
$-0.05
Net margin
-47.1%

EPS came in at -0.41 against a street estimate of -0.05 — a miss of 720.0%.

Key statistics

Market cap
$15.0M
Forward P/E
13.6
P/B
2.47
Book value
$0.51
EPS (TTM)
$-0.98
52-week high
$1.27
52-week low
$0.55
50-day MA
$1.01
200-day MA
$0.93
Beta
0.82

Analyst view

Analysts rate Biofrontera Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $5.88.

Shareholding

Insiders
13.91%
Institutions
22.42%

Largest institutional holders

FundStake
Rosalind Advisors, Inc.9.09%
AIGH Capital Management, LLC7.15%
Geode Capital Management, LLC0.85%
Vanguard Fiduciary Trust Co0.48%
Vanguard Capital Management, LLC0.41%
Susquehanna International Group, LLP0.30%
XTX Topco Ltd0.18%
Citigroup Inc0.09%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Biofrontera Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.